Chronic myeloid leukaemia trials in South Korea
10 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Seoul
- Age
- 1 year to 18 years
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Busan, Jeollanam, Seoul, Uijeongbu-si
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Seoul
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - Phase 1/2Taking peopleA Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Where
- Anyang-si, Busan, Daegu, Uijeongbu-si
- Age
- 18 years to 64 years
- People
- 330 worldwide
- Run by
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
See details and how to joinNCT06163430 · EU 2023-507677-18-00 - Phase 3Taking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Busan, Gyeonggi-do, Seoul, Uijeongbu-si
- Age
- 18 years and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - Phase 3Taking peopleA Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
- Where
- Uijeongbu-si
- Age
- 18 years and over
- People
- 173 worldwide
- Run by
- Il-Yang Pharm. Co., Ltd.
See details and how to joinNCT03459534 - No phaseTaking peopleAsciminib RMP Study
- Where
- Anyang-si, Bucheon-si, Gyeonggi-do, Incheon, Jeollanam, Pusan, Seoul, Suwon, Taegu, Uijeongbu-si, Wŏnju
- Age
- 18 years to 100 years
- People
- 600
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05943522 - Phase 2Taking peopleA Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
- Where
- Incheon
- Age
- 19 years and over
- People
- 69
- Run by
- Korean Society of Hematology
See details and how to joinNCT06368414 - Phase 1Taking peopleA Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Where
- Daegu, Gyeonggi-do, Hwasun, Jeonju, Seoul
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00 - Phase 1/2Taking peopleClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Daegu, Pusan, Seongnam, Seoul
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00